Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Shares Outstanding (Weighted Average): 2013-2025

Historic Shares Outstanding (Weighted Average) for Fortress Biotech (FBIO) over the last 13 years, with Sep 2025 value amounting to $29.8 million.

  • Fortress Biotech's Shares Outstanding (Weighted Average) rose 30.42% to $29.8 million in Q3 2025 from the same period last year, while for Jun 2025 it was $29.6 million, marking a year-over-year increase of 48.47%. This contributed to the annual value of $27.6 million for FY2024, which is 208.69% up from last year.
  • Per Fortress Biotech's latest filing, its Shares Outstanding (Weighted Average) stood at $29.8 million for Q3 2025, which was up 0.63% from $29.6 million recorded in Q2 2025.
  • Fortress Biotech's Shares Outstanding (Weighted Average)'s 5-year high stood at $29.8 million during Q3 2025, with a 5-year trough of $6.3 million in Q1 2021.
  • In the last 3 years, Fortress Biotech's Shares Outstanding (Weighted Average) had a median value of $19.9 million in 2024 and averaged $19.4 million.
  • Data for Fortress Biotech's Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 208.69% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Fortress Biotech's Shares Outstanding (Weighted Average) stood at $6.6 million in 2021, then increased by 9.02% to $7.2 million in 2022, then rose by 23.50% to $8.9 million in 2023, then surged by 208.69% to $27.6 million in 2024, then soared by 30.42% to $29.8 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $29.8 million for Q3 2025, versus $29.6 million for Q2 2025 and $29.5 million for Q1 2025.